Cite
HARVARD Citation
Vasseur, A. et al. (2022). Efficacy of taxanes rechallenge in first-line treatment of early metastatic relapse of patients with HER2-negative breast cancer previously treated with a (neo)adjuvant taxanes regimen: A multicentre retrospective observational study. Breast. pp. 136-144. [Online].